Doctors are increasingly turning to monoclonal-antibody drugs to treat high-risk patients who get sick with Covid-19. WSJ takes a look at how the therapies work and why they’re important for saving lives. Illustration: Jacob Reynolds/WSJ More from the Wall Street…
Wednesday was the deadliest day for the U.S. since the coronavirus pandemic began. CBSN’s Tanya Rivero spoke with John Moore, a professor of microbiology and immunology at Weill Cornell Medical College, about the state of the pandemic.
US regulators on Monday authorized emergency use of the first experimental antibody drug for COVID-19 in patients who are not hospitalized but are at risk of serious illness because of their age or other conditions. Read the story: The US…
President Trump said that he’s recovered from COVID-19 in part thanks to an antibody cocktail. What does this mean and how does an antibody cocktail work? PRODUCTION CREDITS: Produced by: Emily Zendt Production assistance: Glorie Martinez and Christina Monnen Animation:…
More than 38 million cases of COVID-19 have been confirmed worldwide. This comes as drugmaker Eli Lilly says it has paused its trial of a coronavirus antibody treatment to investigate a potential adverse effect. Internal medicine specialist and immunologist Dr.…